Singapore-based Luye Medical Group Signs MOU with China's City of Chongqing for RMB2B Strategic Partnership
- Luye to invest RMB 2 billion (about S$400 million) to develop tertiary general hospitals and specialty centres in Chongqing - MOU will allow Luye to introduce knowledge and expertise from Singapore, Australia, Korea and US to Chongqing - Also in the pipeline: Collaboration with global healthcare organisations to serve Chongqing's nearly 30 million population and greater China
SINGAPORE, Jul 26, 2016 - (ACN Newswire) - Singapore-based Luye Medical Group, has signed a strategic cooperation memorandum of understanding (MOU) with Jiangbei District Government, Chongqing in China to introduce globally renowned healthcare knowledge and expertise into Chongqing and jointly develop healthcare capabilities and services in the city. The MOU was signed by Luye Medical Group's East Asia CEO Mr Guo Wenfei and Chongqing Jiangbei People's Government representative Miss Dai Xiaohong, and witnessed by Chongqing Mayor Mr Huang Qifan and Chairman of Luye Group Mr Liu Dianbo. Through the MOU, both parties will partner to develop private healthcare services and capabilities in Chongqing through collaboration with global healthcare organisations and the transfer of knowledge and expertise into the China healthcare market. Luye Medical Group will invest RMB 2 billion (about S$400 million) in the next few years through the introduction of knowledge, best practices and expertise from Australia, Singapore, Korea and the United States into Chongqing and partner with the Chongqing government to develop high quality private healthcare services and facilities to meet growing demands of the population. The project which covers an area of more than 20 acres, includes the development of tertiary general hospitals and specialty centres which will specialise in oncology, cardiology, orthopaedics, neurology, obstetrics and gynaecology, as well as community facilities to provide comprehensive integrated healthcare services. Mr. Choo Kin Poo, Group Vice President, Strategy Planning & Business Development of Luye Medical Group said, "Through our investment, advanced medical technology, management experiences and global healthcare expertise will be introduced to develop a patient centric comprehensive integrated healthcare system and services that will meet the needs of the Chinese market especially in the medium to higher income group in the southwest region of China."
Mr Choo added, "This is an important milestone for Luye Medical Group Singapore to invest and expand our healthcare business footprint in China. We are pleased to partner with Chongqing, an important city in the Singapore-China third Government to Government project, to kick start our private tertiary hospital and specialty centre development plans. The partnership and investment will further optimize Chongqing's investment and development in healthcare, and the collaboration will become a standard benchmarking project between Singapore and Chongqing China."
On April 18, 2016, Luye successfully acquired Australia's third largest private healthcare group, Healthe Care, paving the way for the Group's expansion in Asia. The acquisition of Healthe Care worth $938 million Australian dollars has leapfrogged Luye Medical Group into the ranks of one of the largest international private medical groups in the region.
About Luye Group
Founded in 1994, Luye Group is an innovative enterprise focused on research and development of innovative drugs, provision of high-end medical services, led by cutting-edge life sciences research, with the aim to become an overall health solutions provider, from prevention, pharmaceutical R&D, clinic treatment to rehabilitation. Under the Luye Group, Luye Medical Group has been making a foray into the international healthcare industry in recent years. Through the successful purchase of Healthe Care, the third largest private hospital group in Australia, a famous obstetrics and gynecology services medical group in South Korea, and a health examination and diagnostic radiology medical centre in Singapore, Luye Medical Group has entered the ranks of China's largest integrated international private medical groups.
About Luye Medical Group
Luye Medical Group is the medical services segment of Luye Group. Headquartered in Singapore, Luye Medical Group has a global presence including China, South Korea, Singapore and Australia. Adhering to the mission of "Professional Technology and Services for Human's Health", Luye Medical Group promotes health and healthcare, with the aim of providing excellent patient-oriented healthcare services for the medium and higher income group, towards becoming the world's most respectable leading company in the healthcare industry.
Through the introduction and innovation of the world's leading medical technology, operational model and management system, Luye Medical Group provides high-standard international healthcare solutions at home and abroad. Luye Medical Group own a series of internationally renowned medical brands including Healthe Care (Australia), AsiaMedic Ltd (Singapore) and Ellium (South Korea). The Group has also established strong collaboration and cooperation with Bobath Memorial Hospital and Goodwill Dental in Korea. Moving forward, the group will be focusing on specialized areas including oncology, neurology, cardiology and orthopedics, Luye Medical Group will continue to introduce global brands and expertise into the China market, to meet people's and patients' need for high quality healthcare services. For more information, please visit http://www.luyemedical.cn/en/.
Issued on behalf of Luye Medicals Group Pte Ltd by: Waterbrooks Consultants Pte Ltd Tel: +65 6100 2228
For media enquiries, please contact: Ms. Jacqueline Lim Mobile: +65 9695 9318 Email: jacqueline@waterbrooks.com.sg
Mr. Ng Wei Joo Mobile: +65 9829 3211 Email: ngweijoo@waterbrooks.com.sg
Source: Luye Medical Group Pte Ltd Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro May 16, 2025 17:21 JST
|  Premiere of New bZ Woodland BEV Focused on Driving Performance and Spaciousness in North America May 16, 2025 16:35 JST
|  Mitsubishi Heavy Industries Activates New Driving Force for Data Center Business in the United States May 16, 2025 15:43 JST
|  MHI Thermal Systems Receives JSRAE Technology Award May 15, 2025 20:08 JST
|  Honda and Quemix Co-develop a New, World's First Quantum State Readout Technology May 15, 2025 13:37 JST
|  Mitsubishi Electric Building Solutions Launches a New Projection-type Hall Lantern for Overseas Markets May 15, 2025 11:00 JST
|  MHI Starts Operation of New CO2 Capture Pilot Plant at KEPCO's Himeji No.2 Power Station May 14, 2025 16:50 JST
|  Making Anime More Interesting and Taking it into the Future, Launch of Three New Projects May 14, 2025 11:00 JST
|  Adyen and JCB launch Card-on-File Tokenization to Enhance Payment Security May 13, 2025 11:00 JST
|  TOYOTA GAZOO Racing fights back for double points finish May 12, 2025 15:45 JST
|  JCB and Arab Bank launch JCB merchant acquiring operations across Jordan May 12, 2025 11:00 JST
|  Mitsubishi Heavy Industries Achieves Highest-Ever Order Intake, Revenue, Net Income, and Free Cash Flow in FY2024, Increases Dividends, and Releases FY2025 Guidance May 09, 2025 18:57 JST
|  Valuufy Selected by Global Tech Leader for Environmental Impact Assessment May 09, 2025 18:00 JST
|  Mazda Adopts North American Charging Standard for BEVs launched in Japan May 09, 2025 16:03 JST
|  Mitsubishi Motors to Launch an All-New BEV Based on Nissan's Next-Generation LEAF in North America in the Second Half of 2026 May 08, 2025 11:25 JST
|  Mitsubishi Motors and Foxtron Sign MOU for OEM Supply of EV May 08, 2025 11:08 JST
|  Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China May 07, 2025 19:06 JST
|  Anime Tokyo Station: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition May 03, 2025 03:00 JST
|  TOYOTA GAZOO Racing Set for Spa spectacle May 02, 2025 19:29 JST
|  FWD Group reports exceptionally strong first quarter new business update May 02, 2025 17:00 JST
|
More Latest Release >>
|